Arrowhead Pharmaceuticals (ARWR) Short Interest Ratio & Short Volume → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free ARWR Stock Alerts $24.77 -0.23 (-0.92%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Arrowhead Pharmaceuticals Short Interest DataCurrent Short Volume9,610,000 sharesPrevious Short Volume8,870,000 sharesChange Vs. Previous Month+8.34%Dollar Volume Sold Short$217.38 millionShort Interest Ratio / Days to Cover7.7Last Record DateApril 30, 2024Outstanding Shares124,200,000 sharesPercentage of Shares Shorted7.74%Today's Trading Volume710,610 sharesAverage Trading Volume1,090,595 sharesToday's Volume Vs. Average65% Short Selling Arrowhead Pharmaceuticals ? Sign up to receive the latest short interest report for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatARWR Short Interest Over TimeARWR Days to Cover Over TimeARWR Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Arrowhead Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,610,000 shares $217.38 million +8.3%N/A7.7 $22.62 4/15/20248,870,000 shares $212.97 million No ChangeN/A7.1 $24.01 3/31/20248,870,000 shares $253.68 million -3.6%N/A6.2 $28.60 3/15/20249,200,000 shares $260.18 million +4.1%N/A5.8 $28.28 2/29/20248,840,000 shares $283.76 million +0.8%N/A5.5 $32.10 2/15/20248,770,000 shares $259.33 million +13.6%N/A5.4 $29.57 Get the Latest News and Ratings for ARWR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,720,000 shares $247.81 million -13.0%N/A5 $32.10 1/15/20248,870,000 shares $323.13 million +18.7%8.8%5.8 $36.43 12/31/20237,470,000 shares $228.58 million -3.5%7.4%5 $30.60 12/15/20237,740,000 shares $220.98 million +1.6%7.7%6.3 $28.55 11/30/20237,620,000 shares $161.54 million -3.3%7.5%6.5 $21.20 11/15/20237,880,000 shares $212.84 million +9.9%7.8%7.9 $27.01 10/31/20237,170,000 shares $176.31 million +0.6%7.1%7.5 $24.59 10/15/20237,130,000 shares $189.66 million +19.0%7.0%7.5 $26.60 9/30/20235,990,000 shares $160.95 million -1.8%5.9%6.6 $26.87 9/15/20236,100,000 shares $176.41 million -3.6%6.0%6.7 $28.92 8/31/20236,330,000 shares $174.96 million +4.5%6.3%7.1 $27.64 8/15/20236,060,000 shares $177.86 million +8.8%6.0%6.8 $29.35 7/31/20235,570,000 shares $192.28 million +8.0%5.5%6.1 $34.52 7/15/20235,160,000 shares $178.54 million +9.3%5.0%5.2 $34.60 6/30/20234,720,000 shares $168.32 million -5.4%4.6%4.6 $35.66 6/15/20234,990,000 shares $178.34 million +1.0%4.9%5 $35.74 5/31/20234,940,000 shares $169.99 million -5.5%4.8%4.4 $34.41 5/15/20235,230,000 shares $208.62 million +8.1%5.1%4.5 $39.89 4/30/20234,840,000 shares $171.38 million -0.8%4.7%4.2 $35.41 4/15/20234,880,000 shares $148.64 million -1.6%4.7%4.7 $30.46 3/31/20234,960,000 shares $125.98 million -9.8%4.8%4.5 $25.40 3/15/20235,500,000 shares $139.26 million +19.1%5.3%4.9 $25.32 2/28/20234,620,000 shares $149.23 million -2.5%4.4%4.7 $32.30 2/15/20234,740,000 shares $161.40 million +3.5%4.6%4.9 $34.05 1/31/20234,580,000 shares $160.25 million -0.7%4.5%4.4 $34.99 1/15/20234,610,000 shares $169.74 million -2.7%4.5%4.6 $36.82 12/30/20224,740,000 shares $192.25 million +11.8%4.6%5 $40.56 12/15/20224,240,000 shares $133.31 million +7.1%4.2%4.8 $31.44 11/30/20223,960,000 shares $127.51 million +6.2%3.8%4.6 $32.20 11/15/20223,730,000 shares $125.55 million -4.4%3.6%4.5 $33.66 10/31/20223,900,000 shares $135.76 million -1.0%3.8%5 $34.81 10/15/20223,940,000 shares $126.16 million +1.8%3.9%5.1 $32.02 9/30/20223,870,000 shares $127.90 million -9.2%3.8%5.1 $33.05 9/15/20224,260,000 shares $149.65 million +1.9%4.2%5.4 $35.13Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. ARWR Short Interest - Frequently Asked Questions What is Arrowhead Pharmaceuticals' current short interest? Short interest is the volume of Arrowhead Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 9,610,000 shares of ARWR short. Learn More on Arrowhead Pharmaceuticals' current short interest. What is a good short interest ratio for Arrowhead Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARWR shares currently have a short interest ratio of 8.0. Learn More on Arrowhead Pharmaceuticals's short interest ratio. Which institutional investors are shorting Arrowhead Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arrowhead Pharmaceuticals: Walleye Trading LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Arrowhead Pharmaceuticals' short interest increasing or decreasing? Arrowhead Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 9,610,000 shares, an increase of 8.3% from the previous total of 8,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Arrowhead Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Arrowhead Pharmaceuticals: Corcept Therapeutics Incorporated (22.07%), TG Therapeutics, Inc. (27.08%), MorphoSys AG (0.83%), Avidity Biosciences, Inc. (11.91%), Amicus Therapeutics, Inc. (9.71%), Maravai LifeSciences Holdings, Inc. (6.66%), Xenon Pharmaceuticals Inc. (3.70%), Merus (5.76%), Bausch Health Companies Inc. (5.73%), MoonLake Immunotherapeutics (14.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Arrowhead Pharmaceuticals stock? Short selling ARWR is an investing strategy that aims to generate trading profit from Arrowhead Pharmaceuticals as its price is falling. ARWR shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arrowhead Pharmaceuticals? A short squeeze for Arrowhead Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARWR, which in turn drives the price of the stock up even further. How often is Arrowhead Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARWR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CORT Short Squeeze TGTX Short Squeeze MOR Short Squeeze RNA Short Squeeze FOLD Short Squeeze MRVI Short Squeeze XENE Short Squeeze MRUS Short Squeeze BHC Short Squeeze MLTX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARWR) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings